Guidance

BCG Vaccine AJV: patient group direction (PGD) template

PGD template to support the administration of BCG Vaccine AJV to individuals under 16 years of age at increased risk of tuberculosis.

From:
UK Health Security Agency
Published
5 September 2018
Last updated
1 August 2023 — See all updates

Applies to England

Documents

BCG Vaccine AJV: patient group direction (PGD) template

Ref: UKHSA gateway number GOV-15081

MS Word Document, 139 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This patient group direction (PGD) template supports the administration of BCG Vaccine AJV, to individuals from birth to 16 years of age, at increased risk of tuberculosis in accordance with the national selective immunisation programme and recommendations given in Chapter 32 of Immunisation Against Infectious Disease: The Green Book.

The BCG AJV PGD version 4.00 is valid from 31 August 2023 to 31 August 2026.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy/procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

Published 5 September 2018
Last updated 1 August 2023 + show all updates

  1. Added version 4, see page 2 for change history.

  2. Added updated PGD (V03.00).

  3. Added V02.00 – routine review.

  4. First published.

Related content